Literature DB >> 32069850

Evaluation of Formulation Parameters on Permeation of Ibuprofen from Topical Formulations Using Strat-M® Membrane.

Pradeep Kumar Bolla1,2, Bradley A Clark2, Abhishek Juluri3, Hanumanth Srikanth Cheruvu4, Jwala Renukuntla2.   

Abstract

Topical drug delivery is an attractive alternative to conventional methods because of advantages such as non-invasive delivery, by-pass of first pass metabolism, and improved patient compliance. However, several factors such as skin, physicochemical properties of the drug, and vehicle characteristics influence the permeation. Within a formulation, critical factors such as concentration of drug, physical state of drug in the formulation, and organoleptic properties affect the flux across the skin. The aim of the study was to develop and investigate topical semisolid preparations (creams and gels) with ibuprofen as the model drug and investigate the effect of various formulation parameters on the in-vitro performance across the Strat-M® membrane using flow-through cells. In addition, the physical stability of the developed formulations was investigated by studying viscosity, pH, and appearance. All the formulations developed in the study had appealing appearance with smooth texture and no signs of separation. Viscosity and pH of the formulations were acceptable. Cumulative amount of drug permeated at the end of 24 h was highest for clear gel (3% w/w ibuprofen; F6: 739.6 ± 36.1 µg/cm2) followed by cream with high concentration of ibuprofen in suspended form (5% w/w; F3: 320.8 ± 17.53 µg/cm2), emulgel (3% w/w ibuprofen; F5: 178.5 ± 34.5 µg/cm2), and cream with solubilized ibuprofen (3% w/w; F2A: 163.2 ± 9.36 µg/cm2). Results from this study showed that permeation of ibuprofen was significantly influenced by formulation parameters such as concentration of ibuprofen (3% vs. 5% w/w), physical state of ibuprofen (solubilized vs. suspended), formulation type (cream vs. gel), mucoadhesive agents, and viscosity (high vs. low). Thus, findings from this study indicate that pharmaceutical formulation scientists should explore these critical factors during the early development of any new topical drug product in order to meet pre-determined quality target product profile.

Entities:  

Keywords:  Permegear flow-through cells; Quality Target Product Profile (QTPP); Strat-M®; emulgel; formulation parameters; ibuprofen; in-vitro permeation test (IVPT); permeation; semi-solid topical formulations; topical bioavailability; topical cream; topical gel

Year:  2020        PMID: 32069850     DOI: 10.3390/pharmaceutics12020151

Source DB:  PubMed          Journal:  Pharmaceutics        ISSN: 1999-4923            Impact factor:   6.321


  16 in total

1.  Valorization of khat (Catha edulis) waste for the production of cellulose fibers and nanocrystals.

Authors:  Tesfaye Gabriel; Kebede Wondu; Jemal Dilebo
Journal:  PLoS One       Date:  2021-02-09       Impact factor: 3.240

2.  Formulation of Topical Dosage Forms Containing Synthetic and Natural Anti-Inflammatory Agents for the Treatment of Rheumatoid Arthritis.

Authors:  Tunde Jurca; Liza Józsa; Ramona Suciu; Annamaria Pallag; Eleonora Marian; Ildikó Bácskay; Mariana Mureșan; Roxana Liana Stan; Mariana Cevei; Felicia Cioară; Laura Vicaș; Pálma Fehér
Journal:  Molecules       Date:  2020-12-23       Impact factor: 4.411

3.  Monoketonic Curcuminoid-Lidocaine Co-Deliver Using Thermosensitive Organogels: From Drug Synthesis to Epidermis Structural Studies.

Authors:  Aryane A Vigato; Ian P Machado; Matheus Del Valle; Patricia A da Ana; Anderson F Sepulveda; Fabiano Yokaichiya; Margareth K K D Franco; Messias C Loiola; Giovana R Tófoli; Cintia Maria S Cereda; Mirela I de Sairre; Daniele R de Araujo
Journal:  Pharmaceutics       Date:  2022-01-27       Impact factor: 6.321

4.  Tailoring thixotropic mixed-lipid nanoconstructs of voriconazole for the management of Vulvovaginal candidiasis: Formulation, statistical optimization, in vitro characterization and in vivo assessment.

Authors:  Wessam H Abd-Elsalam; Yosra Ibrahim Nagy; Samar M Abouelatta
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

5.  Sustainable UV-Crosslinkable Acrylic Pressure-Sensitive Adhesives for Medical Application.

Authors:  Paula Ossowicz-Rupniewska; Paulina Bednarczyk; Małgorzata Nowak; Anna Nowak; Wiktoria Duchnik; Łukasz Kucharski; Joanna Rokicka; Adam Klimowicz; Zbigniew Czech
Journal:  Int J Mol Sci       Date:  2021-10-31       Impact factor: 5.923

6.  Quality by Design for Development, Optimization and Characterization of Brucine Ethosomal Gel for Skin Cancer Delivery.

Authors:  Tamer A Ismail; Tamer M Shehata; Dalia I Mohamed; Heba S Elsewedy; Wafaa E Soliman
Journal:  Molecules       Date:  2021-06-07       Impact factor: 4.411

7.  Transdermal Delivery Systems for Ibuprofen and Ibuprofen Modified with Amino Acids Alkyl Esters Based on Bacterial Cellulose.

Authors:  Paula Ossowicz-Rupniewska; Rafał Rakoczy; Anna Nowak; Maciej Konopacki; Joanna Klebeko; Ewelina Świątek; Ewa Janus; Wiktoria Duchnik; Karolina Wenelska; Łukasz Kucharski; Adam Klimowicz
Journal:  Int J Mol Sci       Date:  2021-06-10       Impact factor: 5.923

8.  Comparison of the In Vitro and Ex Vivo Permeation of Existing Topical Formulations Used in the Treatment of Facial Angiofibroma and Characterization of the Variations Observed.

Authors:  Guillaume Le Guyader; Bernard Do; Victoire Vieillard; Karine Andrieux; Muriel Paul
Journal:  Pharmaceutics       Date:  2020-11-07       Impact factor: 6.321

9.  Comparison of Synthetic Membranes to Heat-Separated Human Epidermis in Skin Permeation Studies In Vitro.

Authors:  Anita Kovács; Stella Zsikó; Fanni Falusi; Erzsébet Csányi; Mária Budai-Szűcs; Ildikó Csóka; Szilvia Berkó
Journal:  Pharmaceutics       Date:  2021-12-07       Impact factor: 6.321

10.  Enhancement of Anti-Inflammatory Activity of Optimized Niosomal Colchicine Loaded into Jojoba Oil-Based Emulgel Using Response Surface Methodology.

Authors:  Heba S Elsewedy; Nancy S Younis; Tamer M Shehata; Maged E Mohamed; Wafaa E Soliman
Journal:  Gels       Date:  2021-12-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.